Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: A longitudinal study

Journal of Alzheimer's Disease

Volumn 21, Issue 4, 2010, Pages 1141-1151

  Julkunen, Valtteri ^a   Niskanen, Eini ^a,b   Koikkalainen, Juha ^c   Herukka, Sanna Kaisa ^b   Pihlajamäki, Maija ^a   Hallikainen, Merja ^b   Kivipelto, Miia ^b,d   Muehlboeck, Sebastian ^e   Evans, Alan C ^e   Vanninen, Ritva ^a   Soininen, Hilkka ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; apolipoprotein E; cortical thickness; magnetic resonance imaging; mild cognitive impairment

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; BRAIN CORTEX; BRAIN SIZE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; CORTICAL THICKNESS; DEMOGRAPHY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FRONTAL CORTEX; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RATING SCALE; RIGHT HEMISPHERE; RISK FACTOR; TEMPORAL CORTEX;

EID: 78650446256     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100114     Document Type: Article

References (44)

1. Qiu C, De Ronchi D, Fratiglioni L (2007) The epidemiology of the dementias: an update. Curr Opin Psychiatry 20, 380-385.
2. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity J Intern Med 256, 183-194.
3. Petersen RC (2001) Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56, 1133.
4. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B; International Psychogeriatric Association Expert Conference on mild cognitive impairment (2006) Mild cognitive impairment. Lancet 367, 1262-1270.
5. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 131, 665-680.
6. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132, 1355-1365.
7. Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC (2005) Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex 15, 995-1001.
8. Singh V, Chertkow H, Lerch JP, Evans AC, Dorr AE, Kabani NJ (2006) Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 129, 2885-2893. (Pubitemid 44684510)
9. Apostolova LG, Steiner CA, Akopyan GG, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM (2007) Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol 64, 1489-1495.
10. Seo SW, Im K, Lee JM, Kim YH, Kim ST, Kim SY, Yang DW, Kim SI, Cho YS, Na DL (2007) Cortical thickness in single-versus multiple-domain amnestic mild cognitive impairment. Neuroimage 36, 289-297.
11. Lerch JP, Pruessner J, Zijdenbos AP, Collins DL, Teipel SJ, Hampel H, Evans AC (2008) Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. Neurobiol Aging 29, 23-30.
12. McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ Jr, Holland D, Koyama A, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative (2009) Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 73, 457-465.
13. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL (2009) The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19, 497-510.
14. Bakkour A, Morris JC, Dickerson BC (2009) The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 72, 1048-1055.
15. Querbes O, Aubry F, Pariente J, Lotterie JA, Demonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P; Alzheimer's Disease Neu-roimaging Initiative (2009) Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 132, 2036-2047.
16. McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler DJ Jr, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative (2009) Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 251, 195-205.
17. Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM (2009) Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage 44, 724-728.
18. Pievani M, Rasser PE, Galluzzi S, Benussi L, Ghidoni R, Sabattoli F, Bonetti M, Binetti G, Thompson PM, Frisoni GB (2009) Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo. Neuroimage 45, 10901098.
19. Drzezga A, Grimmer T, Henriksen G, Miihlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschlager A, Riemen-schneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A (2009) Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology 72, 14871494.
20. Seo SW, Im K, Lee JM, Kim ST, Ahn HJ, Go SM, Kim SH, Na DL (2009) Effects of demographic factors on cortical thickness in Alzheimer's disease. Neurobiol Aging, in press.
21. Bozzali M, Filippi M, Magnani G, Cercignani M, Franceschi M, Schiatti E, Castiglioni S, Mossini R, Falautano M, Scotti G, Comi G, Falini A (2006) The contribution of voxel-based mor-phometry in staging patients with mild cognitive impairment. Neurology 67 453-460.
22. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 56, 16831689.
23. Hanninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soini-nen H (2002) Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scan 106, 148-154.
24. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissi-nen A, Helkala EL, Vainio P, Vanninen R, Partanen K, Soini-nen H (2004) Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 25, 303310.
25. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995) Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273, 1274-1278.
26. Smith GE, Petersen RC, Parisi JE, Ivnik RJ (1996) Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol Cogn 3, 141-147.
27. Berg L (1988) Clinical Dementia Rating (CDR). Psychophar-macol Bull 24, 637-639.
28. American Psychiatric Association (1994) Diagnostic and statistical manual ofmental disorders, 4th edn. Washington, DC:American Psychiatric Association.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices ofDepartment ofHealth and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
30. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T (1993) Determination by PCR-RFLP of apo E genotype in a Japanese popu-lation.J Lab ClinMed 121, 598-602.
31. Lerch JP, Evans AC (2005) Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 24, 163-173.
32. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B (2001) A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 356, 1293-1322.
33. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17, 87-97.
34. Smith SM (2002) Fast robust automated brain extraction. Hum BrainMapp 17, 143-155.
35. Tohka J, Zijdenbos A, Evans A (2004) Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage 23, 84-97.
36. Zijdenbos A (1998) Automatic quantification of MS lesions in 3D MRI brain data sets: Validation of INSECT. 1st. International Conference on Medical Computing and Computer-Assisted Intervention (MICCAI'98) 1496, 439-448.
37. Kim JS, Singh V, Lee JK, Lerch J, Ad-Dab'bagh Y, MacDon-ald D, Lee JM, Kim SI, Evans AC (2005) Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage 27, 210-221.
38. Chung MK, Taylor J (2004) Diffusion Smoothing on Brain Surface via Finite Element Method. Biomedical Imaging: Macro to Nano 1, 425-435.
39. Genovese CR (2002) Thresholding ofstatistical maps in functional neuroimaging using the false discovery rate. Neuroim-age 15, 870-878.
40. Julkunen V, Niskanen E, Muehlboeck S, Pihlajamaki M, Kononen M, Hallikainen M, Kivipelto M, Tervo S, Vanninen R, Evans A, Soininen H (2009) Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer's disease. Dement Geriatr Cogn Disord 28, 404412.
41. Stonnington CM, Tan G, Kloppel S, Chu C, Draganski B, Jack CR Jr, Chen K, Ashburner J, Frackowiak RS (2008) Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease. Neuroimage 39, 1180-1185.
42. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods. Neuroimage 11, 805-821.
43. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P, European Task Force on Age-related White Matter Changes (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-22.
44. Tapiola T, Pennanen C, Tapiola M, Tervo S, Kivipelto M, Hanninen T, Pihlajamaki M, Laakso MP, Hallikainen M, Hamalainen A, Vanhanen M, Helkala E-L, Vanninen R, Nissinen A, Rossi R, Frisoni GB, Soininen H (2008) MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study. Neurobiol Aging 29, 31-38.